background


Product Information:

Ensitrelvir fumarate

S-217622 is a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.

Cat. No.: EX-A5761    Purity: >98%
Chemical
Chemical structure of Ensitrelvir fumarate


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
100mg285In-stock
250mg425In-stock
500mg700In-stock
1g1050In-stock
5g3350In-stock
10g4960In-stock


SynonymsS-217622 fumarate
Synonyms 2S-217622 (2E)-2-butenedioate
CAS No.2757470-18-9
Purity>98%
FormulaC26H21ClF3N9O6
Mol Weight647.95
ColorWhite to off-white
Statesolid powder
SolubilitySoluble in DMSO 100 mg/mL H2O 83.33 mg/mL
Shelf Life>3 years if stored properly
StoragePowder 4°C, sealed storage, away from moisture; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Yuto Unoh, et al. Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. bioRxiv 2022.01.26.477782.

[2]. McKimm-Breschkin JL, et al. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral Res. 2022;197:105227.

CoACoA of Ensitrelvir fumarate
SDSSDS of Ensitrelvir fumarate

KEYWORDS: buy Ensitrelvir fumarate | Ensitrelvir fumarate supplier | purchase | cost | manufacturer | order | distributor | buy 2757470-18-9 | 2757470-18-9 supplier